MYC and acute myeloid leukemia: BRD9 was also reported to support AML cell proliferation and an undifferentiated cell state by sustaining enhancer-mediated MYC expression using its bromodomain, and the inhibition of BRD9 bromodomain selectively suppressed the proliferation of human AML cell lines [47].